Safety, Tolerability and Pharmacokinetics of NTP42:KVA4

NCT04919863 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: NTP42:KVA4
DRUG: Placebo

Sponsor

ATXA Therapeutics Limited

Collaborators

[object Object]